ALC-0159
| |
| Names | |
|---|---|
| Other names
2-[(polyethylene glycol)-2000]-N,N-ditetradecylacetamide
| |
| Identifiers | |
| UNII | |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
| |
ALC-0159 is a
tozinameran.[2]
See also
- Pfizer–BioNTech COVID-19 vaccine nanoparticle ingredients
- ALC-0315
- 1,2-distearoyl-sn-glycero-3-phosphocholine
- Cholesterol
- Others
References
- PMID 33839230.
- ^ "Public Assessment Report Authorisation for Temporary Supply COVID-19 mRNA Vaccine BNT162b2 (BNT162b2 RNA) concentrate for solution for injection" (PDF). Regulation 174. MHRA. 15 December 2020.
- Assessment report, Comirnaty, Common name: COVID-19 mRNA vaccine (nucleoside-modified); Procedure No. EMEA/H/C/005735/0000 - gives structural formula for the compound (p. 24)
 | This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |